Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

London

Investival Showcase

The Ultimate Biotech, Healthtech, and Medtech Networking & Pitching Event. Investival Showcase is a premier event connecting life science executives with investors and strategic partners. [...]

Go to Top